Raphael Pharmaceutical (RAPH) Profit After Tax (QoQ) (2021 - 2024)
Raphael Pharmaceutical (RAPH) Profit After Tax (QoQ) (2021 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Raphael Pharmaceutical | 28.25 Mn | 28.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -21.17% |
| Sep 30, 2024 | -31.45% |
| Jun 30, 2024 | 54.91% |
| Mar 31, 2024 | -550.82% |
| Dec 31, 2023 | 116.83% |
| Sep 30, 2023 | -73.86% |
| Jun 30, 2023 | -57.95% |
| Mar 31, 2023 | 76.07% |
| Dec 31, 2022 | 23.56% |
| Sep 30, 2022 | -130.14% |
| Jun 30, 2022 | -238.92% |
| Mar 31, 2022 | 67.37% |
| Dec 31, 2021 | -36.30% |
| Sep 30, 2021 | -7.49% |
| Jun 30, 2021 | -51.76% |
| Mar 31, 2021 | -10.87% |